Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Surgery
12 evidence topics · 9 sources
Surgery as second-line treatment for abdominal wall tumors
Resection margins
Surgery compared with observation
Surgery after failure of the surveillance approach
“Multiple retrospective single institution case series have reported local control rates after complete surgical resection to be ∼80% at 5 years.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“When the surveillance approach fails, surgery is still a valid option (IV, A).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
NCCN and Desmoid Tumor Working Group positions on first-line surgery
“However, while surgery has historically represented the primary treatment modality for patients with DT, the NCCN Guidelines® and DTWG guidelines no longer support surgery as the first-line option in most situations, given high postsurgical recurrence rates” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“However, consensus guidance also positions surgery as a primary treatment consideration for patients experiencing complications from sporadic mesenteric DT or for those with non-mesenteric DT that progress despite active surveillance or medical treatment” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Indications for surgery and expected recurrence after resection
Surgical morbidity, postsurgical recurrence, and the criterion of tumors not amenable to surgery or radiotherapy
Prospective cohort of 771 cases: surgery compared with wait-and-see
“We conducted a prospective study of 771 confirmed cases of DTF.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Overall, the 2-year EFS was 56%; this value did not differ between patients undergoing an operation and those managed by the wait-and-see approach (53% versus 58%, p = 0.415).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Among patients with favourable locations, the 2-year EFS was similar in patients treated by both surgery (70%) and the wait-and-see approach (63%; p = 0.413). Among patients with unfavourable locations, the 2-year EFS was significantly enhanced in patients initially managed with the wait-and-see approach (52%) compared with those who underwent initial surgery (25%; p = 0.001).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Recurrence after complete gross resection in a single-institution database
“Patients undergoing resection during 1982-2011 for primary or locally recurrent desmoids were identified from a single-institution prospective database.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Desmoids were treated surgically in 495 patients (median follow-up 60 months). Of 439 patients undergoing complete gross resection, 100 (23%) had recurrence. Five-year local recurrence–free survival (LRFS) was 69%. Eight patients died of disease, all after R2 resection.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In multivariate analysis, factors associated with recurrence were extremity location, young age, and large tumor size, but not margin. Abdominal wall tumors had the best outcome (5-year LRFS 91%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Resection margins and local recurrence across sixteen reports
“Sixteen reports were included, consisting of a total of 1295 patients with DF. In patients treated by surgical resection alone, the risk of local recurrence was almost twofold higher for those with microscopically positive resection margins (risk ratio (RR) 1·78, 95 per cent c.i. 1·40 to 2·26).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Recurrence and amputation after surgery reported by participants
“Continued tumor regrowth or recurrence following any DT treatment was reported for 46% (92/202) of participants, with a higher rate post-surgery (63%, 103/163), regardless of tumor location (Fig. 4). Amputation was reported for 7% (12/163) of participants who underwent surgery, with most (83%, 10/12) experiencing tumor regrowth or recurrence post-amputation.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Literature review of recurrence and functional deficits after surgery
“We conducted a literature review to assess the burden of surgery in patients with DT, focusing on recurrence rates and functional deficits resulting from surgeries.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Although surgery is a potential treatment option, complete excision with negative margins is not often possible, the postsurgery recurrence rate is high, and surgery can result in disfigurement and/or loss of function.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Tumors in the extremities have the highest risk of recurrence (30%-90%). Lower rates of recurrences have been reported when radiotherapy was used after surgery (14%-38%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote